Search
Molnupiravir
go.drugbank.com/drugs/DB15661Investigational[A193014] Molnupiravir was granted approval by the UK's Medicines and Health products Regulatory Agency (MHRA) on 4 November 2021 to prevent severe outcomes such as hospitalization and death due to … Molnupiravir (EIDD-2801, MK-4482) is the isopropylester prodrug of [N4-hydroxycytidine].
Categories: Nucleic Acids, Nucleotides, and Nucleosides, Nucleosides and Nucleotides Excl. Reverse Transcriptase InhibitorsProducts: LAGEVRIO® 200MG CAPSULAS, Lagevrio 200mg Hard CapsuleVenous Thromboembolism
go.drugbank.com/conditions/DBCOND0000676Drugs: Acetylsalicylic acid · Betrixaban · Dabigatran etexilate · Dalteparin · Nadroparin · Rivaroxaban +1 moreSynonyms: Acute embolism and thrombosis of unspecified veinJoint sprains
go.drugbank.com/conditions/DBCOND0101640Drugs: EscinSynonyms: (Sprains and strains NOS) or (sprain: [joint NOS] or [ligament NOS] or [muscle NOS] or [rectus sprain] or [tendon NOS]) or (tendon rupture NOS)Ocular hyperemia
go.drugbank.com/conditions/DBCOND0095202Drugs: ChlorpheniramineSynonyms: Conjunctival and scleral injectionrCFP-10
go.drugbank.com/drugs/DB21907ApprovedrCFP-10 is a recombinant culture filtrate protein of _Mycobacterium tuberculosis_ used as an ingredient in the diagnostic agent SIILTIBCY along with [rdESAT-6].[L53638]
Nuclear factor NF-kappa-B
go.drugbank.com/bio_entities/BE0004903TargetHumansThe NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. … The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity
Synonyms: Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Mirikizumab
go.drugbank.com/drugs/DB14910ApprovedInvestigational[L46252] It was officially approved in the EU in May 2023[L48656] and Canada in July 2023[L48661], and was eventually approved in the US in October 2023[L48651] for the treatment of adult patients with … Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsOxilofrine
go.drugbank.com/drugs/DB11610ApprovedOxilofrine is used in combination with [DB11609] as an antitussive. It is currently marketed in Canada by Valeant under the tradename Cophylac.
Congenital Adrenal Hyperplasia (CAH)
go.drugbank.com/conditions/DBCOND0033416Drugs: Betamethasone · Bupivacaine · Cortisone acetate · Crinecerfont · Dexamethasone · Hydrocortisone +7 moreSynonyms: CAH - Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia (CAH)Coronary Artery Disease (CAD)
go.drugbank.com/conditions/DBCOND0032937Synonyms: CAD, Coronary Artery Disease (CAD)